XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jul. 01, 2018
Operating activities:    
Net income $ 104,499 $ 90,087
Loss from discontinued operations and dispositions, net of income taxes 95 621
Income from continuing operations 104,594 90,708
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:    
Restructuring and contract termination charges, net 13,800 6,578
Depreciation and amortization 103,793 88,225
Gain on disposition of businesses and assets, net 2,469 0
Stock-based compensation 12,801 12,148
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 3,161 7,065
Amortization of deferred debt financing costs and accretion of discount 1,790 1,519
Amortization of acquired inventory revaluation 5,565 18,160
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:    
Accounts receivable, net (9,604) (18,768)
Inventories (50,450) (42,993)
Accounts payable (39,951) (24,384)
Accrued expenses and other (106,425) (79,831)
Net cash provided by operating activities of continuing operations 41,543 58,427
Net cash provided by operating activities of discontinued operations 0 0
Net cash provided by operating activities 41,543 58,427
Investing activities:    
Capital expenditures (36,461) (39,608)
Proceeds from surrender of life insurance policies 0 72
Payments to Acquire Investments (868) 0
Purchases of Licenses (5,000) 0
Proceeds from Divestiture of Businesses 550 173
Activity related to acquisitions and investments, net of cash and cash equivalents acquired (244,738) (40,557)
Net cash used in investing activities of continuing operations (286,517) (79,920)
Net cash provided by investing activities of discontinued operations 0 0
Net cash used in investing activities (286,517) (79,920)
Financing activities:    
Payments on borrowings (578,000) (667,000)
Proceeds from borrowings 849,550 342,000
Proceeds from sale of senior debt 0 369,340
Payments of debt financing costs (181) (2,634)
Settlement of cash flow hedges (1,659) (32,711)
Net payments on other credit facilities (9,806) (10,154)
Payments for acquisition-related contingent consideration (23,700) 0
Proceeds from issuance of common stock under stock plans 16,554 8,348
Purchases of common stock (6,057) (4,649)
Dividends paid (15,507) (15,471)
Net Cash Provided by (Used in) Financing Activities, Continuing Operations 231,194 (12,931)
Cash Provided by (Used in) Financing Activities, Discontinued Operations 0 0
Net cash provided by (used in) financing activities 231,194 (12,931)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 685 (4,351)
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent (13,095) (38,775)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period 166,315 202,371
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period 153,220 163,596
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 166,315 $ 202,371